Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target

Acid sphingomyelinase/ceramide system in schizophrenia: implications for therapeutic intervention as a potential novel target

Abstract Schizophrenia is a severe mental illness, as the efficacies of current antipsychotic medications are far from satisfactory. An improved understanding of the signaling molecules involved in schizophrenia may provide novel therapeutic targets. Acid sphingomyelinase (ASM) catalyzes cellular me...

Full description

Bibliographic Details
Main Authors:	Chuanjun Zhuo, Feifei Zhao, Hongjun Tian, Jiayue Chen, Qianchen Li, Lei Yang, Jing Ping, Ranli Li, Lina Wang, Yong Xu, Ziyao Cai, Xueqin Song
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-06-01
Series:	Translational Psychiatry
Online Access:	https://doi.org/10.1038/s41398-022-01999-7

Similar Items

Transcranial direct current stimulation of the occipital lobes with adjunct lithium attenuates the progression of cognitive impairment in patients with first episode schizophrenia
by: Chuanjun Zhuo, et al.
Published: (2022-09-01)

Associations of cognitive impairment in patients with schizophrenia with genetic features and with schizophrenia-related structural and functional brain changes
by: Chuanjun Zhuo, et al.
Published: (2022-08-01)

Validation and reliability test of Chinese language patient-reported impact of symptoms in schizophrenia scale
by: Xiao Lin, et al.
Published: (2023-05-01)

Ceramides and sphingomyelinases in senile plaques
by: Maï Panchal, et al.
Published: (2014-05-01)

Acid Sphingomyelinase-Ceramide System in Bacterial Infections
by: Cao Li, et al.
Published: (2019-02-01)

Lithium bidirectionally regulates depression- and mania-related brain functional alterations without worsening cognitive function in patients with bipolar disorder
by: Chuanjun Zhuo, et al.
Published: (2022-09-01)

Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder
by: Chuanjun Zhuo, et al.
Published: (2022-09-01)

Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls
by: Lea SR, et al.
Published: (2016-09-01)

Activation of Sphingomyelinase-Ceramide-Pathway in COVID-19 Purposes Its Inhibition for Therapeutic Strategies
by: Murad Abusukhun, et al.
Published: (2021-12-01)

Sphingomyelinase D/Ceramide 1-Phosphate in Cell Survival and Inflammation
by: Io-Guané Rivera, et al.
Published: (2015-04-01)

Mechanistic/mammalian target of rapamycin and side effects of antipsychotics: insights into mechanisms and implications for therapy
by: Chuanjun Zhuo, et al.
Published: (2022-01-01)

Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5 [S]
by: Benjamin Newcomb, et al.
Published: (2018-01-01)

Validation of a modified Chinese‐language version of the Davos Assessment of Cognitive Biases Scale (MCL‐DACOBS) in a sample of Chinese patients with schizophrenia
by: Guangdong Chen, et al.
Published: (2023-10-01)

Blockade of Experimental Multiple Sclerosis by Inhibition of the Acid Sphingomyelinase/Ceramide System
by: Katrin Anne Becker, et al.
Published: (2017-11-01)

Baseline global brain structural and functional alterations at the time of symptom onset can predict subsequent cognitive deterioration in drug-naïve first-episode schizophrenia patients: Evidence from a follow-up study
by: Chuanjun Zhuo, et al.
Published: (2022-10-01)

Association between ErbB4 gene function in synaptogenesis and schizophrenia pathogenesis
by: Ranli Li, et al.
Published: (2020-01-01)

Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study
by: Chuanjun Zhuo, et al.
Published: (2023-10-01)

Acid Sphingomyelinase-Ceramide Induced Vascular Injury Determines Colorectal Cancer Stem Cell Fate
by: Christy Li, et al.
Published: (2022-08-01)

Metabolic risk factors of cognitive impairment in young women with major psychiatric disorder
by: Chuanjun Zhuo, et al.
Published: (2022-07-01)

Staphylococcus aureus α-Toxin Induces Inflammatory Cytokines via Lysosomal Acid Sphingomyelinase and Ceramides
by: Jie Ma, et al.
Published: (2017-10-01)

Sphingomyelinase D activity in model membranes: structural effects of in situ generation of ceramide-1-phosphate.
by: Roberto P Stock, et al.
Published: (2012-01-01)

Exploration of the cortical pathophysiology underlying visual disturbances in schizophrenia comorbid with depressive disorder—An evidence from mouse model
by: Jian Liu, et al.
Published: (2021-05-01)

Safety and Efficacy of High-Dose Vitamin B6 as an Adjunctive Treatment for Antipsychotic-Induced Hyperprolactinemia in Male Patients With Treatment-Resistant Schizophrenia
by: Chuanjun Zhuo, et al.
Published: (2021-08-01)

In the era of whole-brain mapping for the exploration of mental disorders, we need to rethink our methods of rodent model establishment
by: Chuanjun Zhuo, et al.
Published: (2022-03-01)

Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells.
by: Alexander Simonis, et al.
Published: (2014-06-01)

DC-SIGN mediated sphingomyelinase-activation and ceramide generation is essential for enhancement of viral uptake in dendritic cells.
by: Elita Avota, et al.
Published: (2011-02-01)

In situ assay of acid sphingomyelinase and ceramidase based on LDL-mediated lysosomal targeting of ceramide-labeled sphingomyelin
by: T Levade, et al.
Published: (1996-12-01)

Polymorphisms in Dopaminergic Genes in Schizophrenia and Their Implications in Motor Deficits and Antipsychotic Treatment
by: Jiaen Ye, et al.
Published: (2019-04-01)

Double-Edged Sword of Tumour Suppressor Genes in Schizophrenia
by: Chuanjun Zhuo, et al.
Published: (2019-02-01)

Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase.
by: Sandra Angulo, et al.
Published: (2011-03-01)

The Pathogenic and Therapeutic Implications of Ceramide Abnormalities in Atopic Dermatitis
by: Masanori Fujii
Published: (2021-09-01)

Testing the validity and reliability of the Chinese version of the Staden schizophrenia anxiety rating scale
by: Chenyuan Du, et al.
Published: (2022-09-01)

Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder
by: Chuanjun Zhuo, et al.
Published: (2022-10-01)

Correction: Probiotic Sonicates Selectively Induce Mucosal Immune Cells Apoptosis through Ceramide Generation via Neutral Sphingomyelinase.
by: PLOS ONE Editors
Published: (2022-01-01)

Correction: Probiotic Sonicates Selectively Induce Mucosal Immune Cells Apoptosis through Ceramide Generation via Neutral Sphingomyelinase
Published: (2022-01-01)

Validity and reliability of a Chinese language suicide screening questionnaire-observer rating (CL-SSQ-OR) assessment for children/adolescents
by: Haiping Yu, et al.
Published: (2023-05-01)

α-TEA-induced death receptor dependent apoptosis involves activation of acid sphingomyelinase and elevated ceramide-enriched cell surface membranes
by: Xiong Ailian, et al.
Published: (2010-10-01)

Metformin Enhances Antidepressant/Antipsychotic Combination Therapy of Schizophrenia With Comorbid Depression in a Murine Model
by: Chunhua Zhou, et al.
Published: (2020-06-01)

Exploring neurometabolic alterations in bipolar disorder with suicidal ideation based on proton magnetic resonance spectroscopy and machine learning technology
by: Jiayue Chen, et al.
Published: (2022-09-01)

Rethinking Schizophrenia and Depression Comorbidity as One Psychiatric Disorder Entity: Evidence From Mouse Model
by: Chunhua Zhou, et al.
Published: (2020-03-01)